Clinical Trials21 May 2023· 3 min read
Pearls for Clinical, Ketamine
Amidst a burgeoning body of research, we're continually unravelling new facets of the versatile drug ketamine. A case in point is recent studies indicating another feather in ketamine's cap: treating
By Tom Okafor, Clinical Trials Correspondent
Clinical Trials16 March 2023· 3 min read
Advancements in Clinical Trials for Lymphoma Cancer Patients
Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. While there are several types of lymphoma, the two main categories are
By Tom Okafor, Clinical Trials Correspondent
Clinical Trials3 March 2023· 3 min read
Lilly's £630M Investment in Novartis' Failed Pain Target.
In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a risky and expensive endeavour, with no gu
By Tom Okafor, Clinical Trials Correspondent
Research8 December 2022· 6 min read
Lecanemab, an Alzheimer's medication, is heralded as a major development.
It has been called "historic" that the first drug to slow the brain damage caused by Alzheimer's has been made. The scientific discovery puts a stop to decades of futility and demonstrates that new me
By Dr. Eleanor Vance, Regulatory Affairs Editor
Pharmaceutical17 November 2022· 5 min read
Mark Cuban's new pharmacy is bringing down the cost of meds
It is still attempting to resolve the fundamental issue. In general, Mark Cuban's new online pharmacy is delivering on its promises of offering low savings on hundreds of prescription medications. The
By Priya Raghavan, Biotech & Markets Analyst